2014 PHD. OK MÅLFRID MANGRUD. IDENTIFICATION OF PATIENTS WITH HIGH AND LOW PROGRESSION OF UROTHELIAL CARCINOMA OF THE URINARY BLADDER STAGE Ta AND T1. SUPERVISOR: EMIEL AM JANSSEN, JAN PA BAAK.

2013 PHD. KRISTIN JONSDOTTIR. COMPARISON OF THE PROGNOSTIC VALUE OF microRNA, GENE-EXPRESSION SIGNATURES AND PROLIFERATION IN EARLY NODE-NEGATIVE BREAST CANCER. SUPERVISOR: EMIEL AM JANSSEN, JAN PA BAAK

2013 PHD WEIWEI FENG. DIAGNOSTIC , PROGNOSTIC AND THERAPEUTIC ASPECTS OF ENDOMETRIAL STROMAL SARCOMAS, LOW GRADE AND UNDIFFERENTIATED ENDOMETRIAL SARCOMA. SUPERVISOR: JAN PA BAAK.

 2012 PHD. ANE CECILIE D MUNK. MOLECULAR BIOMARKERS, HUMAN PAPILLOMAVIRUS -GENOTYPES AND CLINICAL FACTORS IN REGRESSION PREDICTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA GRADES 2-3. SUPERVISOR: SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN

2011 PHD. EINAR GUDLAUGSSON. PROLIFERATION, LYMPH VESSEL INVASION AND HISTOLOGIC TYPE AS PROGNOSTIC FACTORS IN LYMPH NODE NEGATIVE BREAST CANCER. SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN

2011 PHD. KAI ERIK ULEBERG. PROTEOMIC ANALYSIS OF PROTEINS SECRETED BY BIOPSIES CONTAINING CIN 2-3 LESIONS. SUPERVISOR: JAN PA BAAK, EMIEL AM JANSSEN, ANNE HJELLE

2011 PHD. IRENE TVEITERÅS ØVESTAD. EVALUATION OF METHODS FOR THE DETECTION OF PERSISTENT AND REGRESSIVE CIN 2-3 LESIONS. SUPERVISOR: JAN PA BAAK.

2011 PHD. ANITA STEINBAKK. PROGNOSTIC BIOMARKERS IN ENDOMETRIOID ENDOMETRIAL NEOPLASIA. SUPERVISOR: JAN PA BAAK.

2011 PHD. HUI ZHANG. DAX-1 AND APOLIPOPROTEIN D IN BREAST CANCER. SUPERVISORS: JAN PA BAAK, EMIEL AM JANSSEN, HÅVARD SØILAND.

2009 PHD. IVAR SKALAND PROLIFERATION IN BREAST CANCER - IMMUNO HISTOCHEMISTRY AND DIGITAL IMAGE ANALYSIS. SUPERVISOR: JAN P.A. BAAK

2008 PHD. HÅVARD SØILAND. APOLIPOPROTEIN D AND ANDROGEN RECEPTOR IN BREAST CANCER - DETERMINATION METHODS AND ASPECTS OF PROGNOSTICATION. SUPERVISORS: JON ARNE SØREIDE, JAN BAAK, HARTWIG KØRNER

 2007 PHD. KJETIL SØREIDE. METACHRONOUS AND RECURRENT CANCER DEVELOPMENT IN COLORECTAL NEOPLASIA: CLINICAL ASPECTS, MOLECULAR BIOMARKERS AND PROTEOMIC IN SURVEILLANCE AND RISK. SUPERVISOR: JAN BAAK, HARTWIG KØRNER

2007 PHD. EMIEL JANSSEN. PROLIFERATION AND MOLECULAR FACTORS IN LYMPH NODE NEGATIVE BREAST CANCER. SUPERVISOR: JAN BAAK

2004 PHD. MARCO G. BOL. RECURRENCE AND PROGRESSION IN TaT1 UROTHELIAL CELL CARCINOMAS OF THE URINARY BLADDER. SUPERVISOR: JAN P.A.BAAK
(utgår fra Free university of Amsterdam)

2003 Arnold-Jan Krüse
Quantitative biomarkers to identify low and high risk early CIN lesions.
12. desember 2003 . Veilder Prof. Dr. Jan P.A. Baak